Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Ghia

Showing results (11-20 of 373) with videos related to

Pageof 38
Sort By:
Leukemia & Lymphoma|April 7, 2009
Introduction to Chronic Lymphocytic Leukemia Young Investigator's MeetingPaolo Ghia, Bill Wierda
Haematologica|December 2, 2016
Ibrutinib in the real world patient: many lights and some shadesPaolo Ghia, Antonio Cuneo
Blood|May 27, 2021
In CLL, epigenetics also points to the BCRPaolo Ghia, Kostas Stamatopoulos
Oncotarget|May 6, 2017
Reactivating nuclear PTEN to treat CLLRosa Bernardi, Paolo Ghia
Leukemia|April 28, 2018
Minimal residual disease analysis in chronic lymphocytic leukemia: a way for achieving more personalized treatmentsPaolo Ghia, Andy Rawstron
Immunology Letters|October 8, 2013
Reprogramming cell death: BCL2 family inhibition in hematological malignanciesLydia Scarfò, Paolo Ghia
Haematologica|June 2, 2014
Management of chronic lymphocytic leukemiaPaolo Ghia, Michael Hallek
Blood|February 22, 2014
Clonal B-cell lymphocytosis: a new member?Maurilio Ponzoni, Paolo Ghia
Frontiers in Oncology|January 4, 2021
Modeling the Leukemia Microenviroment <i>In Vitro</i>Cristina Scielzo, Paolo Ghia
Blood|April 18, 2024
Ibrutinib in CLL: benefit for all?Antonio Cuneo, Paolo Ghia
Pageof 38

Showing results (11-20 of 373) with videos related to

Sort By:
Pageof 38
Leukemia & Lymphoma|April 7, 2009
Introduction to Chronic Lymphocytic Leukemia Young Investigator's MeetingPaolo Ghia, Bill Wierda
Haematologica|December 2, 2016
Ibrutinib in the real world patient: many lights and some shadesPaolo Ghia, Antonio Cuneo
Blood|May 27, 2021
In CLL, epigenetics also points to the BCRPaolo Ghia, Kostas Stamatopoulos
Oncotarget|May 6, 2017
Reactivating nuclear PTEN to treat CLLRosa Bernardi, Paolo Ghia
Leukemia|April 28, 2018
Minimal residual disease analysis in chronic lymphocytic leukemia: a way for achieving more personalized treatmentsPaolo Ghia, Andy Rawstron
Immunology Letters|October 8, 2013
Reprogramming cell death: BCL2 family inhibition in hematological malignanciesLydia Scarfò, Paolo Ghia
Haematologica|June 2, 2014
Management of chronic lymphocytic leukemiaPaolo Ghia, Michael Hallek
Blood|February 22, 2014
Clonal B-cell lymphocytosis: a new member?Maurilio Ponzoni, Paolo Ghia
Frontiers in Oncology|January 4, 2021
Modeling the Leukemia Microenviroment <i>In Vitro</i>Cristina Scielzo, Paolo Ghia
Blood|April 18, 2024
Ibrutinib in CLL: benefit for all?Antonio Cuneo, Paolo Ghia
Pageof 38